Strattera (atomoxetine) is the first NON-stimulant approved for attention-deficit hyperactivity disorder (ADHD) in Canada

Strattera (atomoxetine) is the first NON-stimulant approved for attention-deficit hyperactivity disorder (ADHD) in Canada.

Unlike stimulants used for ADHD (Ritalin, Dexedrine), Strattera isn't a controlled drug and won't likely be abused.

Strattera blocks the reuptake of norepinephrine, which regulates attention, impulsivity, and activity.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote